Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Autifony Therapeutics has raised €10M across 2 funding rounds, most recently a round in Jun 2014. Based in London, UK; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2014-06-01 | Other | €3.1M | — | View deal → |
| 2011-08-01 | Other | €7.0M | — | View deal → |
